Larvol Delta - MaveropepimutS-a-DPXBased-ImmuneEducating-Therapy-Shows-Promising-and-Durable-Clinical-Benet-in-Patients-with-Recurrent-Ovarian-Cancer-a-Phase-II-Trial

maveropepimut-S (MVP-S) - IMV Inc

https://aacrjournals.org/clincancerres/article/doi/10.1158/1078-0432.CCR-22-2595/727530/Maveropepimut-S-a-DPX-Based-Immune-Educating

Jun 27, 2023

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next